Ashtead Technology has lowered its 2026 revenue and profit expectations after delays in projects across the Middle East, Europe, and the Americas disrupted its second-half trading. The company now expects full-year revenue to be about 5% below market consensus and adjusted EBITA around 15% below consensus. Delays are attributed to ongoing conflict in the Middle East, economic uncertainty, and vessel scheduling changes. Despite the weaker near-term outlook, Ashtead maintains a strong balance sheet and remains confident in its long-term growth strategy supported by customer backlog and focus on energy security.
Injective Institutional Services has received official transfer agent registration from the U.S. Securities and Exchange Commission, allowing it to maintain securities ownership records directly on blockchain networks. This regulatory milestone enabl...
Mila Resources has identified strong copper and gold drill targets at its Monal project in Queensland using induced polarisation surveys. These surveys revealed signs of a porphyry system at the Basilica prospect, with mineralisation potentially 200-...
Solana spot ETFs in the US recorded $1.58 million in net inflows on August 18, bringing total inflows to $1.16 billion. SOL price peaked at $86 before slightly retreating to around $84.81, with $100 identified as a key resistance level that could con...
As of 17 August 2026, over 2.2 million ETH are stuck in Ethereum's staking deposit queue, causing a wait time of roughly 39 days before new validators begin earning rewards. This delay is due to a protocol cap limiting new activations to 256 ETH ever...
Injective's affiliate, Injective Institutional Services, has become a U.S. SEC-registered transfer agent, enabling it to maintain official securities ownership records and process ownership changes on its Layer 1 blockchain network. This registration...
